1.Wang AJ, Peng AP, Li BM, Gan N, Pei L, Zheng XL, et al. Natural history of covert hepatic encephalopathy: An observational study of 366 cirrhotic patients. World J Gastroenterol. 2017; 23(34): 6321-9.
2.Bajaj JS, Reddy KR, Tandon P, Wong F, Kamath PS, Garcia-Tsao G, et al. The 3-month readmission rate remains unacceptably high in a large North American cohort of patients with cirrhosis. Hepatology. 2016; 64(1): 200-208.
3.Yildirim M. Falls in Patients With Liver Cirrhosis. Gastroenterol Nurs. 2017; 40(4): 306-310.
4.Vilstrup H, Amodio P, Bajaj J, Cordoba J, Ferenci P, Mullen KD, et al. Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study of Liver Diseases and the European Association for the Study of the Liver. Hepatology. 2014; 60(2): 715-735.
5.Barone M, Shahini E, Iannone A, Viggiani MT, Corvace V, Principi M, et al. Critical flicker frequency test predicts overt hepatic encephalopathy and survival in patients with liver cirrhosis. Dig Liver Dis. 2018; 50(5): 496-500.
6.Cavaggioni G, Poli E, Ferri F, Parlati L, Monaco V, Melcore C, et al. MELDNa score is associated with psychopathology and reduced quality of life in cirrhotic patients with a liver transplant perspective. Metab Brain Dis. 2017; 32(3): 923-933.
7.Chaney A, Werner K T, Kipple T. Primary Care Management of Hepatic Encephalopathy: A Common Cirrhosis Complication. The Journal for Nurse Practitioners. 2015; 11(3): 300-306.
8.Hanai T, Shiraki M, Watanabe S, Kochi T, Imai K, Suetsugu A, et al. Sarcopenia predicts minimal hepatic encephalopathy in patients with liver cirrhosis. Hepatol Res. 2017; 47(13): 1359-1367.
9.Jepsen P, Watson H, Andersen PK, Vilstrup H. Diabetes as a risk factor for hepatic encephalopathy in cirrhosis patients. Journal of Hepatology. 2015; 63(5): 1133-1138.
10.Tsai CF, Chen MH, Wang YP, Chu CJ, Huang YH, Lin HC, et al. Proton Pump Inhibitors Increase Risk for Hepatic Encephalopathy in Patients With Cirrhosis in A Population Study. Gastroenterology. 2017; 152(1): 134-141.
11.Bajaj JS, Sanyal AJ, Bell D, Gilles H, Heuman DM. Predictors of the recurrence of hepatic encephalopathy in lactulose-treated patients. Aliment Pharmacol Ther. 2010; 31(9): 1012-1017.
12. Riggio O, Amodio P, Farcomeni A, Merli M, Nardelli S, Pasquale C, et al. A Model for Predicting Development of Overt Hepatic Encephalopathy in Patients With Cirrhosis. Clin Gastroenterol Hepatol. 2015; 13(7): 1346-1352.
13.Tapper EB, Parikh ND, Sengupta N, Mellinger J, Ratz D, Lok AS, et al. A risk score to predict the development of hepatic encephalopathy in a population-based cohort of patients with cirrhosis. Hepatology. 2018; 68(4): 1498-1507.
14.Chen L, Jiang L, Shen A, Wei W. Development of a quality instrument for assessing the spontaneous reports of ADR/ADE using Delphi method in China. Eur J Clin Pharmacol. 2016; 72(9): 1135-1142.
15. de Villiers MR, de Villiers PJ, Kent AP. The Delphi technique in health sciences education research. Med Teach. 2005; 27(7): 639-643.
16.Saberifiroozi M. Improving Quality of Care in Patients with Liver Cirrhosis. Middle East J Dig Dis. 2017; 9(4): 189-200.
17.Han S, Zhu R, Cheng J, Yue X. Re-discussing the content of the prescription rights of midwives under certain circumstances using the Delphi method. Chinese Nursing Research. 2017; 4(3): 146-150.
18.Putnam J W, Spiegel A N, Bruininks R H. Future directions in education and inclusion of students with disabilities: a Delphi investigation. Exceptional Children. 1995; 61(n6): 553-576.
19.Albuquerque MR, Lopes MC, de Paula JJ, Faria LO, Pereira ET, da Costa VT. Cross-Cultural Adaptation and Validation of the MPAM-R to Brazilian Portuguese and Proposal of a New Method to Calculate Factor Scores. Front Psychol. 2017; 8: 261.
20.Lakanmaa RL, Suominen T, Perttilä J, Ritmala-Castrén M, Vahlberg T, Leino-Kilpi H. Basic competence in intensive and critical care nursing: development and psychometric testing of a competence scale. J Clin Nurs. 2014; 23(5-6): 799-810.
21.Labenz C, Toenges G, Huber Y, Nagel M, Marquardt JU, Schattenberg JM, et al. Development and Validation of a Prognostic Score to Predict Covert Hepatic Encephalopathy in Patients With Cirrhosis. Am J Gastroenterol. 2019.
22. Bager P. The assessment and care of patients with hepatic encephalopathy[J]. Br J Nurs. 2017; 26(13):724-729.
23.Tapper EB, Finkelstein D, Mittleman MA, Piatkowski G, Chang M, Lai M. A Quality Improvement Initiative Reduces 30-Day Rate of Readmission for Patients With Cirrhosis. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY. 2016; 14(5): 753-759.
24.Künzler-Heule P, Beckmann S, Mahrer-Imhof R, Semela D, Händler-Schuster D. Being an informal caregiver for a relative with liver cirrhosis and overt hepatic encephalopathy: a phenomenological study. JOURNAL OF CLINICAL NURSING. 2016; 25(17-18): 2559-2568.
25.Gimenes FR, Reis RK, da Silva PC, Silva AE, Atila E. Nursing Assessment Tool for People With Liver Cirrhosis. Gastroenterol Nurs. 2016; 39(4): 264-272.